Standard Biotools (LAB) Net Equity Issued and Repurchased (2017 - 2022)
Standard Biotools (LAB) posted quarterly Net Equity Issued and Repurchased of $202.7 million for Q2 2022, up 908.46% quarter-over-quarter from $20.1 million in Q3 2020.
Standard Biotools (LAB) Net Equity Issued and Repurchased (2017 - 2022) Analysis & Trends
Standard Biotools (LAB) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $202.7 million the latest figure, recorded in Q2 2022.
- In Q2 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $202.7 million; the TTM figure through Sep 2023 stood at $202.7 million (changed 0.0% YoY), while the FY2022 annual figure was $225.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $202.7 million in Q2 2022 per LAB's latest filing, from $20.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $202.7 million in Q2 2022 and bottomed at $20.1 million in Q3 2020.
- Historically, Net Equity Issued and Repurchased has averaged $103.8 million across 4 years, with a median of $96.1 million in 2018.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 117914.0% in 2018 and fell as far as 117914.0% in 2018.
- Standard Biotools' Net Equity Issued and Repurchased stood at $58.9 million in 2018, then soared by 126.29% to $133.3 million in 2019, then plunged by 84.92% to $20.1 million in 2020, then jumped by 908.46% to $202.7 million in 2022.
- Business Quant data shows LAB's Net Equity Issued and Repurchased at $202.7 million in Q2 2022, $20.1 million in Q3 2020, and $133.3 million in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Standard Biotools | 250.59 Mn | -226.13 Mn | 10.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 202.70 Mn |
| Jun 30, 2022 | 202.70 Mn |
| Sep 30, 2020 | 20.10 Mn |
| Sep 30, 2020 | 20.10 Mn |
| Mar 31, 2019 | 133.30 Mn |
| Mar 31, 2019 | 133.30 Mn |
| Dec 31, 2018 | 58.91 Mn |
| Dec 31, 2018 | 58.91 Mn |
| Dec 31, 2017 | -50,000.00 |
| Dec 31, 2017 | -50,000.00 |